BioSpace
Five Biggest Biopharma Takeovers of 2025
Here, BioSpace looks back at the biggest acquisition deals of 2025. Target: Intra-Cellular Therapies Acquisition date: ...
Zacks Investment Research on MSN
Here's how AbbVie's neuroscience portfolio is aiding top-line growth
AbbVie ABBV has built a substantial neuroscience franchise. While the segment was initially anchored by Botox Therapeutic and ...
Healio
FDA approves self-administered nasal spray for paroxysmal supraventricular tachycardia
Please provide your email address to receive an email when new articles are posted on . The FDA approved a rapid-acting nasal spray for the treatment of acute symptomatic paroxysmal supraventricular ...
WebMD
Cardamyst: FDA Approves First Rapid-Acting Self-Use Nasal Spray for Sudden Fast Heartbeats (PSVT)
What Is Cardamyst, and Why Does It Matter? Cardamyst (etripamil) is a new nasal spray for treating sudden episodes of fast heartbeats, known as paroxysmal supraventricular tachycardia (PSVT), and ...
MassDevice
Johnson & Johnson MedTech submits Ottava surgical robot to FDA
Johnson & Johnson MedTech announced today that it submitted its Ottava surgical robotic system to the FDA for de novo ...
FiercePharma
Milestone wins 1st-ever FDA approval with green light for heart arrhythmia nasal spray
Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has given Milestone Pharmaceuticals its first FDA approval in its 22-year history. The ...
TCTMD
Etripamil Nasal Spray Gains FDA Approval for Acute Paroxysmal SVT
The US Food and Drug Administration has approved etripamil nasal spray (Cardamyst) for adults with acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT), drugmaker Milestone ...
KOAT Albuquerque
FDA expands recall on New Mexico nasal spray due to contamination
AVAILABLE OPTIONS TO STAY ON TRACK. THE FDA HAS EXPANDED ITS RECALL OF A NASAL SPRAY PRODUCED HERE IN NEW MEXICO. THE MEDINATURA PRODUCTS CONTAINED DANGEROUS LEVELS OF YEAST, MOLD AND MICROBIAL ...
Seeking Alpha
Milestone Pharmaceuticals Inc. (MIST) Discusses FDA Approval and Clinical Insights for CARDAMYST Nasal Spray in PSVT Treatment Transcript
Greetings. Welcome to Milestone Pharmaceuticals CARDAMYST FDA Approval Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to Michael Wood ...
Morningstar
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
Aptar Group, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that its Bidose (BDS) Liquid Nasal Spray System is the ...
USA Today
Nasal spray sold nationwide recalled. See affected products.
A pharmaceutical company has expanded a recall on nasal spray products because of possible yeast, mold and microbial contamination, which could lead to infections. MediNatura New Mexico, Inc. issued ...
Benzinga.com
Milestone Wins FDA Approval For First Self-Use Nasal Spray For Sudden Fast Heartbeats
The approval marks Cardamyst as the first FDA-approved treatment in over 30 years for more than 2 million Americans with PSVT. Cardamyst nasal spray is a novel and rapid-acting calcium channel blocker ...